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Barrier dysfunction or drainage 
reduction: differentiating causes of CSF protein 
increase
Mahdi Asgari1,2, Diane A. de Zélicourt1 and Vartan Kurtcuoglu1,2,3* 
Abstract 
Background: Cerebrospinal fluid (CSF) protein analysis is an important element in the diagnostic chain for various 
central nervous system (CNS) pathologies. Among multiple existing approaches to interpreting measured protein lev-
els, the Reiber diagram is particularly robust with respect to physiologic inter-individual variability, as it uses multiple 
subject-specific anchoring values. Beyond reliable identification of abnormal protein levels, the Reiber diagram has 
the potential to elucidate their pathophysiologic origin. In particular, both reduction of CSF drainage from the cranio-
spinal space as well as blood–CNS barrier dysfunction have been suggested ρas possible causes of increased concen-
tration of blood-derived proteins. However, there is disagreement on which of the two is the true cause.
Methods: We designed two computational models to investigate the mechanisms governing protein distribution in 
the spinal CSF. With a one-dimensional model, we evaluated the distribution of albumin and immunoglobulin G (IgG), 
accounting for protein transport rates across blood–CNS barriers, CSF dynamics (including both dispersion induced 
by CSF pulsations and advection by mean CSF flow) and CSF drainage. Dispersion coefficients were determined a 
priori by computing the axisymmetric three-dimensional CSF dynamics and solute transport in a representative seg-
ment of the spinal canal.
Results: Our models reproduce the empirically determined hyperbolic relation between albumin and IgG quotients. 
They indicate that variation in CSF drainage would yield a linear rather than the expected hyperbolic profile. In con-
trast, modelled barrier dysfunction reproduces the experimentally observed relation.
Conclusions: High levels of albumin identified in the Reiber diagram are more likely to originate from a barrier dys-
function than from a reduction in CSF drainage. Our in silico experiments further support the hypothesis of decreas-
ing spinal CSF drainage in rostro-caudal direction and emphasize the physiological importance of pulsation-driven 
dispersion for the transport of large molecules in the CSF.
© The Author(s) 2017. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Background
Despite continued advances in non-invasive medical 
imaging, cerebrospinal fluid (CSF) analysis in general and 
CSF protein analysis in particular have remained impor-
tant tools for the diagnosis of various disorders of the 
central nervous system (CNS) [1]. Yet while it is accepted 
that abnormal changes in CSF protein content are indica-
tive of pathological conditions, the reasons leading to the 
measured protein concentrations are often a matter of 
debate [2].
While some proteins found in the CSF are synthe-
sized within the CNS (choroid plexus, brain and spine) 
or the meninges, most of them originate in the blood 
serum under normal conditions [2–4]. They pass through 
blood-CNS barriers (either the blood–brain barrier, BBB, 
or blood-CSF barrier, BCSFB) into CNS fluids [5]. Equi-
librium between the rate-limited influx of serum derived 
proteins through these barriers and their efflux with CSF 
drainage determines the protein content of the CSF [6]. 
Changes in the concentrations of these proteins may thus 
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reflect alterations in either (1) serum protein levels, (2) 
intrathecal protein synthesis [7], (3) barrier properties 
[8], or (4) CSF dynamics and drainage [2].
Since protein levels in the CSF show normal fluctua-
tions as serum protein concentrations change, and since 
there are inter-individual variations, it is helpful to use 
relative values for diagnostic purposes. The Reiber dia-
gram constitutes a standardized approach to assessing 
such values. Should, for example, the immunoglobulin G 
(IgG) concentration in a patient’s CSF sample be analyzed, 
its relative value with respect to serum IgG concentration 
(IgG quotient) is compared to the corresponding relative 
concentration of albumin (albumin quotient). Since albu-
min is not synthesized in the mature CNS [2], a higher 
than expected IgG quotient for the given albumin quo-
tient is seen as evidence for intrathecal synthesis of IgG 
and thus for an inflammatory process in the CNS. When 
there is no intrathecal immunoglobulin synthesis, Reiber 
noted a hyperbolic relationship between immunoglobu-
lin and albumin quotients as shown in Fig. 1, and stated 
that the albumin quotient should remain below 0.01 for 
normal subjects [2]. He further defined upper and lower 
bounds for the relationship between the two quotients, 
both of which also follow a hyperbolic function, and noted 
that the relative spread of these bounds, as quantified by 
a population variation coefficient, remains constant over 
the entire range of investigated albumin levels (Fig. 1b).
Of the four possible causes for changes in CSF pro-
tein concentration listed above, the Reiber diagram cor-
rects for variations in serum protein levels and identifies 
intrathecal protein synthesis (see Fig.  1a). However, it 
cannot distinguish between changes in CNS barrier 
properties and changes in CSF dynamics and drainage, 
both of which have been hypothesized as possible causes 
for abnormal albumin quotients [2, 8, 9]. In this study, we 
have employed a set of computational tools to test these 
two competing hypotheses.
To this end, we have analysed how changes in barrier func-
tion, CSF drainage rates and pulsatility translate to changes 
of albumin and IgG quotients in the Reiber diagram, where 
IgG was chosen from the family of immunoglobulins arbi-
trarily as a common biomarker for inflammatory neuro-
logical disorders [10]. Our models reproduce the empirical 
mathematical relationship between the two quotients given 
by Reiber, quantify the effect of CSF pulsation on protein 
distribution and show that barrier dysfunction rather than 
decreased cerebrospinal fluid drainage is the likely cause of 
abnormally high albumin values in the Reiber diagram. Our 
results further emphasize the pathophysiological impor-
tance of dispersion, CSF drainage and blood-CNS barrier 
Fig. 1 Variation of the immunoglobulin G quotient with that of albumin as depicted in Reiber diagrams. a Displays the empirically established 
relationship between the concentration of IgG in CSF relative to its concentration in blood serum (IgG quotient,  QIgG) and the correspondingly 
defined albumin quotient  (QAl). b Depicts the normal range of albumin quotients, corresponding to the area in a marked with the black square. 
Reiber demonstrated that the average quotient variation (black line) and upper and lower bounds (green dashed lines) follow the hyperbolic 
function QIgG = ab
√
Q2Al + b
2 − c [32]. He also showed that the population variation coefficient (CV), defined for a given albumin quotient as 
CV =
QIgG
0.5·
(
QIgGupperlimit+QIgGlowerlimit
), remains constant over the entire range of investigated albumin quotients.  QIgG values above the upper bound are 
indicative of a blood-CNS barrier dysfunction
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permeability for the transport of large molecules in the spi-
nal subarachnoid space.
Methods
We designed two computational models (Fig. 2) to inves-
tigate the mechanisms governing protein distribution in 
the spinal CSF and underlying reasons for pathological 
changes in protein levels. With a one-dimensional model 
(presented second), we evaluate the distribution of albu-
min and IgG in the spinal CSF, accounting for the protein 
transport rate across blood-CNS barriers, CSF dynamics 
(including both dispersion induced by CSF pulsations and 
advection by mean CSF flow) and CSF drainage from the 
cranio-spinal space. We also study the impact of patho-
logical changes in barrier permeability, CSF dynamics 
and drainage on these distributions. The dispersion coef-
ficients used in this one-dimensional model to account for 
CSF pulsations are determined a priori by computing the 
axisymmetric three-dimensional CSF dynamics and solute 
transport in a representative segment of the spinal canal.
Three‑dimensional model of protein dispersion induced 
by CSF pulsation
Dispersion as the combined effect of diffusion and advec-
tion by pulsatile fluid motion with zero net flow is the gov-
erning mechanism for the faster transport of solutes in the 
CSF compared to pure diffusion [11–14]. To determine 
dispersion coefficients of albumin and IgG along the spine, 
we first solve the axisymmetric three-dimensional Navier–
Stokes equations and associated advection–diffusion equa-
tion for protein transport in a segment of the spinal canal.
Model characteristics
The geometry of the spinal canal is idealized as an 
axisymmetric annular pipe (Fig.  3c) with dimensions 
based on statistical geometrical values reported in the lit-
erature [15, 16]. The thickness of the spinal subarachnoid 
space varies from cervical region to lumbar space within 
the range of 3.5–4.5  mm [17]. We have used the mean 
Fig. 2 Study flow chart. This flow chart describes the application of the two computational models developed to test hypothesis about the cause 
of increased CSF albumin quotients. The modeling steps and hypotheses are framed by rectangles and rhombi, respectively, while model inputs 
and outputs are shown without bounding boxes
Fig. 3 Schematic of the model domains. a A representation of the 
cerebrospinal fluid compartments. The x and arrow parallel to the 
spinal cord indicate the anatomic correspondence and orienta-
tion of the one-dimensional model. This orientation was chosen 
to match the direction in which CSF samples are accessed during 
sequential sampling of CSF through lumbar puncture [31]. b Protein 
efflux locations in the spine. Blood-derived proteins pass from blood 
by diffusion into the CSF space and exit it along nerve roots. c A 
representation of the three-dimensional model domain as an annular 
channel. The boundary conditions for this model are shown on the 
domain surfaces
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measured value for this thickness in the model, 4  mm 
[17]. The segment length is chosen to be long enough 
to avoid the influence of boundary conditions on pro-
tein transport rates. All geometrical parameters used are 
reported in Table 1.
The model domain is treated as porous, with perme-
ability and porosity metrics according to literature val-
ues for the subarachnoid space [18]. A velocity (flow) 
boundary condition derived from MRI measurements of 
spinal CSF [19] is imposed at the inlet boundary (proxi-
mal site), while a constant pressure boundary condi-
tion is imposed at the outlet (distal site). Both the inner 
and outer boundaries of the spinal canal are treated as 
impermeable walls with zero slip and zero solute flux 
conditions. Constant solute concentration is imposed at 
the axial boundaries.
Table 1 Model parameters
Parameter Value References
Barrier permeability for albumin Pb [μg/min]
In the cortical subarachnoid space 29.4 [27]
In the ventricular space 7.6 [27]
In the spinal space 4.8 [27]
CSF compartments volume [ml]
Ventricular space 30
Cortical subarachnoid space 90
Spinal subarachnoid space 30
Protein and pore size used in the membrane pore model for barrier permeability [nm]
Pore radius, r 19.4 [6]
Albumin hydrodynamic radius, aAl 3.58 [6]
Immunoglobulin G hydrodynamic radius, aIgG 5.34 [6]
CSF production and drainage rate
CSF total production and drainage rate, F [ml/day] 500 [30]
CSF pulsation
CSF pulsation amplitude in the cervical region [mm/s] 10 [25]
CSF pulsation amplitude in the lumbar region [mm/s] 0 [24]
CSF pulsation time period [s] 0.8 [25]
CSF physical properties
Density, ρ [kg/m3] 1000
Viscosity, µ [Pa s] 0.001
Spinal canal porosity and permeability
Porosity, ε 0.99 [21]
Permeability in the longitudinal direction,  Klongitudinal  [m
2] 1.45 · 10−7 [21]
Permeability in the radial direction,  Kradial  [m
2] 2.36 · 10−8 [21]
CSF albumin concentrations
Albumin concentration in the lumbar CSF [mg/ml] 0.363 [27]
Albumin CSF/blood quotient in the lumbar space 0.002 [31]
Albumin quotient ratio (lumbar to cisternal) 2 [27]
Albumin quotient ratio (cortical subarachnoid space to cisternal) 3 [27]
Dimensions [mm]
Spinal cord diameter 10 [16, 17]
Spinal subarachnoid space thickness, w 4 [16, 17]
Spinal segment length 100
Spine length between cistern and lumbar space 700
Protein properties  [m2/s]
Albumin diffusion coefficient,  DAl 6 · 10−11
Immunoglobulin G diffusion coefficient,  DIgG 2.4 · 10−11
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Solution methodology
The time-dependent equations governing fluid motion 
and solute transport, namely modified Navier–Stokes 
with Darcy’s law for the porous medium, continuity and 
advection–diffusion equations, are solved numerically 
using the open source finite volume code OpenFOAM 
[20]:
where the unknowns u, P and C are, respectively, the fluid 
velocity, pressure, and protein concentration. The param-
eters µ and ρ are the dynamic viscosity and density of the 
cerebrospinal fluid, respectively, ε and K the porosity and 
permeability of the spinal canal, and D the diffusion coef-
ficient of the respective protein. The permeability of the 
spinal subarachnoid space is derived using the solution 
presented by Gupta et al. [21]. The parameter values are 
reported in Table 1.
Equations  (1) to (3) are discretized using an implicit 
Euler scheme for the temporal derivatives and central 
differencing for the first and second order spatial deriva-
tives. All calculations are conducted with a time step size 
of  10−4  s and spatial resolution of 100 μm in both axial 
and radial directions. Grid and time-step independence 
were confirmed.
Evaluation of the dispersion coefficient
The dispersion coefficient may be derived from the 
above three-dimensional model by fitting the simulated 
axial concentration with the analytical solution of the 
dispersion equation in a semi-infinite domain [11]:
where x is the spatial coordinate in axial direction, t is 
time, C0 is the initial concentration, and D∗L is the dis-
persion coefficient in a segment of length L. For a finite 
domain, this approximation is valid as long as the pen-
etration Fourier number for the domain length remains 
small [22]. The value of D∗L is determined by fitting 
Eq. (4) to the results of the axisymmetric simulations at 
t =  8  s (10 cycles of pulsations). For further details on 
the dispersion coefficient evaluation, we refer the reader 
to [11].
(1)∂u
∂t
+ (u · ∇)u−
µ
ρ
∇
2
u = −
1
ρ
∇P−
µε
Kρ
u,
(2)∇ · u = 0,
(3)∂C
∂t
= (u · ∇)C+ D∇
2
C,
(4)C(x, t)
C0(x)
= erfc
(
x
2
√
D∗Lt
)
,
One dimensional model of protein distribution in the 
spinal CSF
Our one-dimensional domain represents protein trans-
port in the spinal CSF between the lumbar and cervical 
regions. The model domain is illustrated in Fig.  3a. We 
solve the one-dimensional advection–diffusion equation 
modified to include sink and source terms representing 
protein drainage and influx, respectively, as schematically 
shown in Fig. 3b:
where C(x,t) is the CSF protein concentration at time t 
and in axial location x, and u is the CSF bulk flow veloc-
ity. D* is the protein dispersion coefficient induced by 
CSF pulsation obtained from our three-dimensional 
model. The source term,  Si, represents the influx of serum 
proteins into the CSF, while the sink term,  So, represents 
protein efflux due to CSF drainage [23]. The dimensions 
of the domain are reported in Table 1.
Evaluation of the dispersion coefficient D*
The dispersion coefficient depends on both the solute 
considered and the amplitude of the CSF pulsations. The 
latter has been shown to increase from zero in the lum-
bar space [24] to a maximum of about 10  mm/s in the 
cervical region [25]. Accordingly, we applied our three-
dimensional model to characterize the dispersion coeffi-
cients of albumin and IgG for CSF pulsation amplitudes 
ranging between 0 and 10 mm/s. The corresponding dis-
persion values are reported in results section. Expectedly, 
dispersion equals to diffusion for the pulsation ampli-
tude of zero (i.e. in the lumbar space) and increases for 
the higher pulsation amplitudes, reaching a maximum for 
10 mm/s velocity (i.e. in the cervical space). Since there 
is an almost linear relation between the imposed velocity 
and calculated dispersion coefficient, we consider a linear 
increase of the dispersion coefficient from D∗
min
 equal 
to the pure diffusion coefficient in the lumbar space to a 
value of D∗max in the cervical region.
Evaluation of the source term
In absence of active transporters in the blood vessel wall 
for albumin and immunoglobulins, the only transport 
mechanism for these larger proteins through the barrier 
is slow paracellular diffusion [26]. Therefore, the source 
term for the CSF concentration could be written as:
where  Pb stands for the diffusive permeability of the 
blood-CNS barriers for the protein under consideration 
(5)∂C
∂t
=
∂
2D∗C
∂x2
+
∂uC
∂x
+ Si − So,
(6)Si = Pb · (Cblood − C),
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and Cblood is the serum protein concentration. The per-
meability of the barrier to albumin molecules in differ-
ent regions of the CSF compartments has been measured 
with radioactive studies [27]. However, it is not known 
how this permeability might change due to barrier open-
ing. In order to model such permeability variations 
in pathological situations, we use the membrane pore 
model described in [6], which was demonstrated to accu-
rately capture barrier permeability for different proteins. 
In this model, permeability depends on the ratio of pro-
tein size to pore size:
where a and r are protein hydrodynamic radius and pore 
radius, respectively. These values are reported in Table 1. 
Barrier permeability to IgG molecules can be described 
in the same way.
Evaluation of the sink term
Since protein efflux occurs by CSF drainage [23], the pro-
tein efflux pathways are the same as for CSF [28]. These 
include the arachnoid granulations mainly expressed in 
the cranial space but to a minor extent also in the spinal 
subarachnoid space, and outflow paths along nerves in 
both cranial and spinal spaces [29]. Thus, the drainage 
sink term can be written as
where F is the CSF drainage rate. The total CSF turn-over 
rate has been estimated to 500  ml/day in humans [30]. 
However, the distribution of the corresponding drain-
age between cranial and spinal compartments is not 
fully known [30], let alone its distribution along the spi-
nal axis. To address this issue, we leverage available data 
on the spatial distribution of albumin concentrations at 
steady state, namely the known relative concentrations 
of albumin in the cisterns, lumbar and cortical subarach-
noid spaces, and reported albumin concentration gradi-
ents along the spinal subarachnoid space.
At steady state, the average concentration in a given 
compartment can be derived from Eq.  5 and is estab-
lished by the balance of the source and sink terms. Equat-
ing the source and sink terms given in Eqs. 6 and 8, we 
obtain the following expression for the albumin quotient, 
 QAl, in a given CSF compartment [6]:
where the subscript c represents the CSF compartment 
for which  QAl is known, namely the cisterns, cortical or 
(7)
Pb ∝ (1− (a/r))
2
·
[
1− 2.1 · (a/r)+ 2.09 · (a/r)3
−0.95 · (a/r)5
]
,
(8)So = F · C ,
(9)QAl =
Pbc
Pbc + Fc
,
spinal subarachnoid spaces,  Pbc stands for the barrier 
permeability in that compartment and Fc for the mean 
CSF drainage rate to be determined. The corresponding 
results are reported in Table 3. The obtained mean drain-
age characteristics for the spinal compartment, Fspinal , 
are then employed as baseline for other tested scenarios.
Having calculated the mean CSF drainage rate for the 
spinal compartment, we determine its local value by 
making use of reported albumin concentration gradients 
along the neuraxis. Due to the low CSF turnover rate, 
sequential sampling of CSF through a lumbar puncture 
allows one to sequentially access CSF portions from the 
lumbar, thoracic and finally cervical subarachnoid spaces. 
Using this method, a decrease of  QAl was observed 
from the first 0–3 ml of CSF to the last 27–30 ml of CSF 
obtained by lumbar puncture [31]. Having an opposite 
gradient in CSF drainage has been hypothesized as the 
most probable mechanism for these changing CSF pro-
tein concentrations [6]. Accordingly, we assume spinal 
CSF drainage to increase linearly from zero at x =  0 in 
the lumbar sac (end of lumbar region) to twice Fspinal  in 
the cervical region, thereby ensuring that the average spi-
nal drainage matches the above determined value, Fspinal  . 
Note that only at exactly x = 0 is CSF drainage zero, but 
that integrated over a segment, for example along the 
lumbar region, there is CSF drainage.
Solution method
Equation  (5) for solute transport is discretized using 
finite differences in Matlab with a forward Euler time 
stepping scheme and second order central differences for 
the spatial second derivatives. Neumann boundary con-
ditions of zero flux for concentrations are imposed on the 
proximal end of the cervical region and the distal end of 
the lumbar space. These zero flux boundary conditions 
are reasonable due to the closed end of the lumbar and 
the steady-state equilibrium between protein influx and 
efflux in the lumped compartment of cranial space. The 
equation is solved with a time-step size of 6 s and a spa-
tial resolution of 3.5 mm, with confirmed time-step and 
grid independence.
The Reiber diagram
Reiber showed that a hyperbolic function can describe 
the relationship between albumin and immunoglobu-
lin quotients seen in a population of patients without 
intrathecal production of immunoglobulins [32]:
where a, b and c are parameters appropriately chosen to fit 
the measured patient values. We use this empirical relation-
ship as a reference for the output of the protein distribution.
(10)QIgG = a
b
√
Q2Al + b
2 − c,
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Reiber further showed that the population variation 
coefficient, CV, stays constant as the albumin quotient 
changes. CV is defined as the ratio of the IgG variation to 
its mean value [32]:
Results
Transport of the molecules in the spinal canal
We interrogated the 3D axisymmetric model to evalu-
ate protein transport resulting from pulsatile spinal CSF 
motion. The diffusion coefficients of albumin and IgG 
in CSF are 6  ·  10−11 and 2.4  ·  10−11  m2/s, respectively. 
A peak CSF velocity of 10 mm/s was considered as Ref. 
[25]. The resulting dispersion coefficients are sum-
marized in Table  2. Since the CSF pulsation amplitude 
reduces along the spinal canal towards the lumbar space 
(11)CV =
QIgGupperlimit − QIgGlowerlimit
0.5 ·
(
QIgGupperlimit + QIgGlowerlimit
) ,
[24], we also calculated the dispersion coefficient for 
lower velocities. Puy et  al. showed that CSF pulsations 
can change in pathological situations [33], demonstrat-
ing an up to four fold increase in amplitude. To evaluate 
the impact of such pathological variations on protein dis-
tribution, we also calculated dispersion coefficients for 
accordingly increased velocities. We observed an almost 
linear increase in the dispersion coefficients with increas-
ing velocity amplitude.
Distribution of albumin and IgG in the spinal CSF: baseline 
condition
We first determined the distribution of CSF drainage 
between cortical and spinal spaces as outlined in the 
"Methods" section and then calculated albumin and IgG 
quotients using the one-dimensional model. Drainage 
distribution and albumin quotients in different regions 
of the CSF space are summarized in Table 3. The distri-
bution of albumin and IgG quotients in the spinal canal 
between lumbar and cervical regions is shown in Fig. 4.
Table 2 Calculated protein dispersion coefficients
Molecule Diffusion coef‑
ficient  (m2/s)
Maximum 
CSF velocity 
(mm/s)
Dispersion coef‑
ficient  (m2/s)
Immunoglobu-
lin G
2.4 · 10−11 10 4.0 · 10−8
Albumin 6.0 · 10−11 2.5 2.8 · 10−9
5 2.2 · 10−8
10 6.0 · 10−8
20 1.3 · 10−7
40 2.7 · 10−7
Table 3 CSF drainage distribution and  albumin quotients 
in different CSF compartments
CSF drainage distribution
Cortical region 82%
Spinal region 18%
Albumin quotients in different CSF compartments
Lumbar region 0.002
Cortical subarachnoid space 0.003
Cistern 0.001
Fig. 4 Albumin (a) and IgG (b) quotient distributions in the spinal cerebrospinal fluid. x is the normalized location on the rostro-caudal axis from 
lumbar (x = 0) to cervical space (x = 1) as illustrated in Fig. 3a. Quotients are obtained using spinal CSF drainage rates calculated as outlined in the 
“Methods” section. Permeability of the blood-CNS barrier to IgG is obtained using Eq. (7)
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Impact of CSF pulsation amplitude change on protein 
distribution
We employed the 1D model of albumin distribution in 
conjunction with the dispersion rates obtained using 
the 3D model of protein transport in the spinal space to 
assess the effect of changes in CSF pulsation amplitude. 
We investigated the effect of a fourfold increase in CSF 
pulsation amplitude observed in chronic hydrocepha-
lus patients [33] and used the corresponding dispersion 
coefficient calculated in the previous section. Figure  5 
shows the impact of CSF pulsation amplitude change on 
the steady state albumin distribution in the spinal CSF. 
An increase in CSF velocity amplitude results in a more 
even albumin distribution in the spinal canal, whereas a 
decrease intensifies the concentration gradient.
Impact of barrier dysfunction and CSF drainage on protein 
quotients
We used the 1D model to investigate the effect of changes 
in blood-CNS barrier permeability and CSF drainage on 
albumin and IgG quotients in the lumbar cerebrospinal 
fluid. Figure 6a shows the relationship between IgG and 
albumin quotients in the cases of barrier permeabil-
ity change (circles) and CSF drainage rate change (solid 
black line). An albumin quotient of 0.002 is taken as the 
nominal value. Decrease in CSF drainage and increase in 
barrier permeability lead to increased IgG and albumin 
quotients, and vice versa. The empirical hyperbolic rela-
tion between albumin and IgG quotients derived by 
Reiber [2] from measurements in patients’ CSF samples 
is shown to match well with our calculations for barrier 
permeability change (solid red line).
Figure  6b illustrates the effect of change in barrier 
permeability for three different constant CSF drainage 
rates. The center (dashed) curve corresponds to nomi-
nal drainage, while the upper and lower solid curves 
correspond to 30% increased and decreased drainage 
rates, respectively. All three curves are hyperbolic. We 
used the upper and lower curves to calculate represen-
tations of the population variation coefficient, obtain-
ing values of 0.48, 0.44 and 0.4 for albumin quotients 
of 0.001, 0.002 and 0.003, respectively. Note that the 
population variation coefficient determined by Reiber 
based on patient data is constant over a range of albu-
min quotients.
Figure 6c illustrates the effect of change in barrier per-
meability for three different baseline IgG permeabili-
ties, reflecting the variation of the barrier permeability 
to IgG to different extent than for albumin as shown by 
Seyfert et al. [34]. The center (dashed) curve corresponds 
to nominal baseline IgG permeability, while the upper 
and lower solid curves correspond to 30% increased and 
decreased baseline IgG permeability, respectively. The 
representation of the population variation coefficient is 
in this case 0.6 for all albumin quotients.
Discussion
The biochemical analysis of the cerebrospinal fluid is 
an important diagnostic tool for pathologies of the 
CNS. For example, changes in CSF immunoglobulin 
content can be indicative of inflammatory reactions in 
the brain. To account for inter-individual and normal 
intra-individual variability, it is advantageous to assess 
relative rather than absolute values of protein concen-
tration as done in the Reiber diagram. While the Reiber 
diagram can indicate intrathecal synthesis of proteins, it 
is debated whether higher than normal readings of rela-
tive albumin concentrations are indicative of CNS bar-
rier dysfunction or reduction in CSF drainage. Here we 
have employed a set of computational models to assess 
which one of these two changes is the more likely cause 
of increased albumin concentration in CSF relative to 
that in the blood plasma.
The Reiber diagram features a hyperbolic relationship 
between albumin quotient and, for example, IgG quo-
tient, where ‘quotient’ refers to the concentration of the 
respective protein in CSF relative to its concentration in 
blood plasma. Reiber derived this empirical relationship 
from measurements in a large set of patients in which 
intrathecal synthesis of the protein of interest could be 
Fig. 5 Impact of changes in CSF pulsation amplitude on the steady 
state albumin quotient distribution. x is the normalized location on 
the rostro-caudal spinal axis from lumbar (x = 0) to cervical space 
(x = 1) in Fig. 3a. The solid black line represents the nominal condition 
with CSF velocity pulsation amplitude of 10 mm/s (dispersion coef-
ficient of 6 · 10−8 m2/s), the red dashed and blue dashed-dotted lines 
represent conditions with a factor of four pulsation amplitude reduc-
tion or increase, respectively (dispersion coefficients: 6 · 10−8 and 
3.6 · 10−8 m2/s, respectively). Higher CSF velocity amplitudes reduce 
albumin gradients in the spinal cerebrospinal fluid space
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excluded. He hypothesized that this non-linear relation-
ship was caused by inter-patient variability in CSF drain-
age rates [32]. However, as shown in Fig. 6a, our models 
indicate that variations in the rate of CSF drainage would 
yield a linear relationship between the quotients rather 
than the experimentally determined hyperbolic one. 
Reiber also calculated the variation coefficient for his 
patient database and found it to be constant for a large 
range of albumin quotients. Our calculations show 
that the variation coefficient does not stay constant for 
Fig. 6 Relationship between IgG quotient and albumin quotient as commonly shown in the Reiber diagram. a Blue circles show how isolated 
changes in barrier permeability shape the relation between IgG and albumin quotients, while the black solid line demonstrates the corresponding 
effect of isolated changes in CSF drainage rate. The albumin quotient of 0.002 is taken as the nominal value. Decrease in CSF drainage and increase 
in barrier permeability lead to increased IgG and albumin quotients, and vice versa. Quotient variations due to changes in barrier permeability are 
perfectly described by the hyperbolic function (Eq. 10) empirically derived by Reiber (red solid line,  Rsquare = 1). In contrast, quotient variations due 
to changes in CSF drainage follow a linear trend. b Quotient variation due to barrier permeability change. The dashed line represents nominal CSF 
drainage conditions, while the upper and lower solid lines are representative of 30% increased and decreased CSF drainage rates, respectively. The 
population variation coefficient for albumin quotients of 0.001, 0.002, 0.003 is, respectively, 0.48, 0.44 and 0.4. c The effect of barrier permeability 
change for three different baseline IgG permeabilities. The dashed line represents the nominal IgG permeability and upper and lower solid lines repre-
sent 30% increased and decreased IgG baseline permeability, respectively. The calculated variation coefficient is constant (with a value of 0.6) for all 
albumin quotients
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different baseline CSF drainage values (Fig. 6b), indicat-
ing that inter-patient variability in CSF drainage alone 
may not result in the protein quotient relationship 
observed by Reiber. One should thus not, without fur-
ther case-dependent evidence, attribute abnormally high 
albumin quotients identified in the Reiber diagram to 
reduced CSF drainage.
Others have attributed increased albumin quotients 
to blood-CNS barrier dysfunction. Indeed, as shown 
in Fig.  6a, variation in barrier permeability leads to the 
expected hyperbolic relationship between protein quo-
tients. This is further confirmed by a constant population 
variation coefficient as illustrated in panel (c) for different 
baseline IgG permeabilities. Consequently, high albumin 
quotients identified in the Reiber diagram may be seen as 
indicative of a CNS barrier dysfunction.
Our calculations of the distribution of CSF efflux indi-
cate 18% drainage in the spinal compartment and 82% 
drainage in the cranial compartment. This distribu-
tion matches well with the measurements of Marmarou 
et  al. [35] in cats, where absorption in the spinal space 
accounted for 16% of the total CSF drainage and the cra-
nial space contributed 84%. Similar results were obtained 
by Gehlen et al. using a lumped parameter model of cou-
pled cardiovascular and CSF dynamics [36]. Albumin 
quotients calculated based on this drainage distribution 
are within the range of values obtained experimentally in 
healthy subjects [31].
Seyfert et  al. measured albumin and immunoglobulin 
concentration gradients in the spinal CSF by sequential 
CSF sampling through lumbar puncture. They showed a 
decreasing protein concentration profile from lumbar to 
cervical space [31]. It was hypothesized that this concen-
tration gradient results from the variation of CSF drain-
age along the spine [6]. Our calculations show that the 
hypothesized drainage gradient along the spinal canal 
with minimum drainage rate in the lumbar space would, 
indeed, result in a longitudinal concentration gradient for 
albumin and IgG (Fig. 4). Therefore, our results support 
the existence of rostro-caudally decreasing spinal CSF 
drainage.
Puy et  al. correlated the magnitude of CSF pulsation 
with protein distribution in different CSF compartments 
[33]. We calculated the dispersion rate of albumin in the 
spinal CSF for different pulsation amplitudes as reported 
in Table 2, and employed these values in our global pro-
tein distribution model. Increased CSF pulsation dimin-
ishes the longitudinal concentration gradient  in the 
spinal canal, while reduced pulsation intensifies it (Fig. 5). 
These results are in line with the measurements of Puy 
et al. [33]. Therefore, changed CSF dynamics in patholo-
gies such as hydrocephalus and Chiari malformation 
could have an impact on protein distribution in the spinal 
canal.
The two computational models developed in this study 
have the following main limitations: First and foremost, 
we have simplified the spinal canal anatomy substantially 
to a 3D axisymmetric annular conduit and a 1D repre-
sentation, respectively, considering the spinal subarach-
noid space as a porous medium. Both the macroscopic 
anatomy as well as the microanatomy of the CSF spaces 
as defined by, e.g. arachnoid trabeculae, could play an 
important role in fluid and solute dynamics. Neglecting 
the microanatomy can lead to discrepancies between 
computed and measured metrics of spinal CSF dynam-
ics [19]. In our models, the effect of microstructures is 
approximated by the introduction of anisotropic perme-
ability of the porous medium representing the spinal sub-
arachnoid space.
The second main limitation pertains to the issue of 
parameter uncertainty. For instance, we have consid-
ered the overall CSF drainage rate to be equal to the 
estimated value of CSF production, which itself is only 
known approximatively [30]. We have dealt with param-
eter uncertainty by performing sensitivity analyses, 
which show that our main conclusions are robust with 
respect to reasonable variations of the model param-
eters. Concretely, we have shown that the hyperbolic 
protein quotient function in the Reiber diagram that 
results from variation in barrier permeability does 
not depend on baseline CSF drainage (Fig.  6b) or IgG 
permeability values (Fig.  6c). We have also made sure 
that the population variation coefficient does not only 
stay constant for a 30% change in IgG baseline perme-
ability (Fig.  6c), but also for much larger and smaller 
changes (up to 100% change). Finally, we checked that 
the derived dispersion coefficients do not depend on the 
computational domain length and hydraulic conductiv-
ity of the domain.
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